Evanston, IL, United States of America

Ti Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Osi Pharmaceuticals, Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ti Wang. Retrieved from https://idiyas.com/inventor/ti-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ti Wang: Innovator in Pharmaceutical Chemistry

Introduction

Ti Wang is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Ti Wang holds a patent for Furo[3,2-C]pyridines, specifically focusing on Furo[3,2-c]Pyridine and Thieno[3,2-c]pyridine compounds of Formula I. This patent encompasses the preparation, intermediates, pharmaceutical compositions, and uses of these compounds, particularly in the treatment of diseases such as cancers. His work addresses conditions in which epithelial-mesenchymal transition (EMT) is involved, as well as conditions mediated by protein kinase activity, including RON and/or MET.

Career Highlights

Ti Wang is currently associated with Osi Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Ti Wang has collaborated with notable colleagues, including An-Hu Li and Arno G Steinig, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ti Wang's contributions to pharmaceutical chemistry, particularly through his patent on Furo[3,2-C]pyridines, highlight his role as an influential inventor in the field. His ongoing work at Osi Pharmaceuticals, Inc. continues to pave the way for advancements in disease treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…